MoneyWorks4Me

Cadila Healthcare - Quaterly Results

29 Oct 2021 Evaluate
The revenue declined to Rs. 20089.00 millions for the quarter ended September 2021 as compared to Rs. 20569.00 millions during the corresponding quarter last year.A radical decline of -97.02% was reported in the net profit of the company for the quarter ended September 2021 to Rs. 141.00  millions from Rs. 4730.00 millions.Operating Profit reported a sharp decline to 5537.00 millions from 6884.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 20089.00 20569.00 -2.33 41323.00 38528.00 7.25 77904.00 63474.00 22.73
Other Income 694.00 608.00 14.14 991.00 808.00 22.65 789.00 8494.00 -90.71
PBIDT 5537.00 6884.00 -19.57 12010.00 12976.00 -7.44 23980.00 22725.00 5.52
Interest 241.00 149.00 61.74 683.00 348.00 96.26 709.00 2339.00 -69.69
PBDT 2103.00 6735.00 -68.78 8134.00 12628.00 -35.59 21396.00 19866.00 7.70
Depreciation 1192.00 1121.00 6.33 2359.00 2230.00 5.78 4511.00 4289.00 5.18
PBT 911.00 5614.00 -83.77 5775.00 10398.00 -44.46 16885.00 15577.00 8.40
TAX 770.00 884.00 -12.90 1635.00 1686.00 -3.02 2123.00 2041.00 4.02
Deferred Tax 43.00 -111.00 -138.74 58.00 -150.00 -138.67 -910.00 400.00 -327.50
PAT 141.00 4730.00 -97.02 4140.00 8712.00 -52.48 14762.00 13536.00 9.06
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 27.56 33.47 -17.65 29.06 33.68 -13.70 30.78 35.80 -14.02
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..